focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK shares end higher on earnings optimism; AstraZeneca gains

Tue, 16th Mar 2021 09:12

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Just Group jumps on strong earnings
* Unite Group rises on upbeat outlook
* UBS bullish on FTSE 100 in 2021
* Midcaps end near 13-month high
* FTSE 100 up 0.8%, FTSE 250 adds 1.1%

(Updates to close)
By Shivani Kumaresan and Amal S
March 16 (Reuters) - London's FTSE 100 rose on Tuesday
following a clutch of upbeat company earnings, while AstraZeneca
rose after the European medicine watchdog said it saw little
reason to change its stance on the drugmaker's COVID-19 vaccine.
The blue-chip FTSE 100 index ended 0.8% higher at
its best close since early January, with financials, healthcare
and consumer staples stocks among the best performers.
AstraZeneca was the top boost to the index after the
European Medicines Agency (EMA) head, Emer Cooke, said she saw
no reason to change its recommendation of the vaccine. The EMA
is still investigating concerns over the shot's safety and will
release its findings on Thursday.
"The market is starting to appreciate that higher yields are
not necessarily a bad thing for stocks, as long as they reflect
higher growth and inflation expectations," said Andrea Cicione,
head of strategy at TS Lombard.
"Over the last few sessions, investors are gaining a bit
more confidence and are getting comfortable with growth again."

A recent rise in treasury yields had hampered an otherwise
strong start to the year for UK stocks, as investors feared a
bigger-than-expected spike in inflation as economies began to
reopen.
Meanwhile, brokerage UBS in a note said it remained bullish
on UK equities and raised its FTSE 100 year-end target from
7,200 to 7,600, a 17.6% premium to its 2020 close.
The energy sector was the top laggard for the day, as lower
oil prices resulted in losses in oil heavyweights BP Plc
and Royal Dutch Shell Plc .
The domestically focused FTSE 250 index rose 1.1% to
a near 13-month high, almost completely recovering its losses
from the coronavirus crisis.
Specialist pension provider Just Group Plc rose
5.2% after it reported an 11% rise in annual earnings and
flagged progress in shoring up its capital base.
Student housing provider Unite gained 2.2%, after it
forecast a return to full occupancy and rental growth for the
upcoming academic year and reinstated dividend for the
pandemic-hit 2020.

(Reporting by Shivani Kumaresan and Amal S in Bengaluru;
Editing by Arun Koyyur and Lisa Shumaker)


More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.